Actavis, Allergan Could Announce Merger Deal Monday
A deal between the two pharmaceutical companies would make it nearly impossible for Valeant Pharmaceuticals and investor Bill Ackman to takeover the combined company.
The announcement of a merger deal could come as early as Monday, reports persons familiar with the matter.
Actavis closed Friday at $243.77, a gain of $2.14 (0.89 percent), while Allergan shares gained $2.44 (1.24 percent) to close at $198.65.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.